Market Cap

Avecho Biotechnology Limited Market Capitalization:

A$9.5 Million

AUD as of Jan. 1, 2024

US$6.5 Million

business Avecho Biotechnology Limited Company Profile

Avecho Biotechnology Limited Main Stock Listing

ASX: AVE

Market Capitalization History of Avecho Biotechnology Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Avecho Biotechnology Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$9.5 M -63.05%
Jan. 1, 2023 A$25.7 M 7.69%
Jan. 1, 2022 A$23.9 M -35.00%
Jan. 1, 2021 A$36.8 M 400.00%
Jan. 1, 2020 A$7.4 M 0.00%
Jan. 1, 2019 A$7.4 M -76.47%
Jan. 1, 2018 A$31.2 M -33.04%
Jan. 1, 2017 A$46.7 M 271.20%
Jan. 1, 2016 A$12.6 M -91.13%
Jan. 1, 2015 A$141.8 M -31.30%
Jan. 1, 2014 A$206.4 M -23.34%
Jan. 1, 2013 A$269.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Avecho Biotechnology Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Avecho Biotechnology Limited has the following listings and related stock indices.


Stock: ASX: AVE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.